A detailed history of Lcnb Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lcnb Corp holds 19,153 shares of MRK stock, worth $1.95 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
19,153
Previous 19,963 4.06%
Holding current value
$1.95 Million
Previous $2.47 Million 11.98%
% of portfolio
0.77%
Previous 0.93%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $90,031 - $104,465
-810 Reduced 4.06%
19,153 $2.18 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $6,437 - $6,913
-52 Reduced 0.26%
19,963 $2.47 Million
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $44,163 - $51,460
-390 Reduced 1.91%
20,015 $2.64 Million
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $100 - $109
-1 Reduced -0.0%
20,405 $2.22 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $16,163 - $17,949
-157 Reduced 0.76%
20,406 $2.1 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $32,583 - $35,514
-300 Reduced 1.44%
20,563 $2.37 Million
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $141,027 - $157,358
-1,370 Reduced 6.16%
20,863 $2.22 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $44,769 - $57,400
-512 Reduced 2.25%
22,233 $2.47 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $52,915 - $59,444
626 Added 2.83%
22,745 $1.96 Million
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $62,617 - $70,980
750 Added 3.51%
22,119 $2.02 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $10,291 - $11,536
-140 Reduced 0.65%
21,369 $1.75 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $661,362 - $828,441
9,150 Added 74.04%
21,509 $1.65 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $70,963 - $78,041
990 Added 8.71%
12,359 $928,000
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $105,465 - $116,655
1,500 Added 15.2%
11,369 $884,000
Q1 2021

May 13, 2021

SELL
$68.86 - $81.11 $28,301 - $33,336
-411 Reduced 4.0%
9,869 $761,000
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $21,954 - $24,885
-300 Reduced 2.84%
10,280 $853,000
Q2 2020

Aug 12, 2020

SELL
$70.42 - $80.13 $23,942 - $27,244
-340 Reduced 3.11%
10,580 $818,000
Q1 2020

May 11, 2020

BUY
$63.36 - $87.82 $38,016 - $52,691
600 Added 5.81%
10,920 $840,000
Q4 2019

Feb 10, 2020

SELL
$77.58 - $87.54 $15,516 - $17,508
-200 Reduced 1.9%
10,320 $938,000
Q3 2019

Nov 08, 2019

BUY
$76.08 - $82.93 $66,417 - $72,397
873 Added 9.05%
10,520 $886,000
Q2 2019

Aug 01, 2019

SELL
$69.84 - $81.59 $3,561 - $4,161
-51 Reduced 0.53%
9,647 $809,000
Q4 2018

Feb 19, 2019

SELL
$65.24 - $75.71 $3,261 - $3,785
-50 Reduced 0.51%
9,698 $741,000
Q3 2018

Nov 09, 2018

SELL
$57.69 - $67.84 $17,307 - $20,352
-300 Reduced 2.99%
9,748 $692,000
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $1,270 - $1,493
25 Added 0.25%
10,048 $610,000
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $8,408 - $9,772
-165 Reduced 1.62%
10,023 $546,000
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $9,652 - $11,526
187 Added 1.87%
10,188 $574,000
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $19,067 - $20,517
325 Added 3.36%
10,001 $641,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,676
9,676 $620,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Lcnb Corp Portfolio

Follow Lcnb Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.